カテゴリー： Market Monitor Global, 世界, 医療/バイオ

注射用オマリズマブの世界市場見通し2023年-2029年

◆英語タイトル：Omalizumab for Injection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5824）◆商品コード：MMG23JU5824
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Omalizumab for Injection Market 調査レポートは次の情報を含め、グローバルにおけるの注射用オマリズマブ市場規模と予測を収録しています。・世界の注射用オマリズマブ市場：売上、2018年-2023年、2024年-2029年
・世界の注射用オマリズマブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用オマリズマブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射用皮下粉末」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

注射用オマリズマブのグローバル主要企業は、Roche、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、注射用オマリズマブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の注射用オマリズマブ市場：タイプ別、2018年-2023年、2024年-2029年
世界の注射用オマリズマブ市場：タイプ別市場シェア、2022年
・注射用皮下粉末、皮下液（150mg/mL）、皮下液（75mg/0.5mL）

世界の注射用オマリズマブ市場：用途別、2018年-2023年、2024年-2029年
世界の注射用オマリズマブ市場：用途別市場シェア、2022年
・病院、診療所

世界の注射用オマリズマブ市場：地域・国別、2018年-2023年、2024年-2029年
世界の注射用オマリズマブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における注射用オマリズマブのグローバル売上、2018年-2023年
・主要企業における注射用オマリズマブのグローバル売上シェア、2022年
・主要企業における注射用オマリズマブのグローバル販売量、2018年-2023年
・主要企業における注射用オマリズマブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Novartis

*************************************************************

・調査・分析レポートの概要
注射用オマリズマブ市場の定義
市場セグメント
世界の注射用オマリズマブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用オマリズマブ市場規模
世界の注射用オマリズマブ市場規模：2022年 VS 2029年
世界の注射用オマリズマブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用オマリズマブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用オマリズマブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：注射用皮下粉末、皮下液（150mg/mL）、皮下液（75mg/0.5mL）
注射用オマリズマブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所
注射用オマリズマブの用途別グローバル売上・予測

・地域別市場分析
地域別注射用オマリズマブ市場規模 2022年と2029年
地域別注射用オマリズマブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Novartis
...

Omalizumab is used to control and prevent symptoms caused by asthma that is due to year-round allergens.
This report aims to provide a comprehensive presentation of the global market for Omalizumab for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omalizumab for Injection. This report contains market size and forecasts of Omalizumab for Injection in global, including the following market information:
Global Omalizumab for Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Omalizumab for Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Omalizumab for Injection companies in 2022 (%)
The global Omalizumab for Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Subcutaneous Powder For Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Omalizumab for Injection include Roche and Novartis etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Omalizumab for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omalizumab for Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Omalizumab for Injection Market Segment Percentages, by Type, 2022 (%)
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)
Global Omalizumab for Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Omalizumab for Injection Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Omalizumab for Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Omalizumab for Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omalizumab for Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Omalizumab for Injection revenues share in global market, 2022 (%)
Key companies Omalizumab for Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Omalizumab for Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Omalizumab for Injection, market overview.
Chapter 2: Global Omalizumab for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Omalizumab for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Omalizumab for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Omalizumab for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Omalizumab for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Omalizumab for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Omalizumab for Injection Overall Market Size
2.1 Global Omalizumab for Injection Market Size: 2022 VS 2029
2.2 Global Omalizumab for Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Omalizumab for Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Omalizumab for Injection Players in Global Market
3.2 Top Global Omalizumab for Injection Companies Ranked by Revenue
3.3 Global Omalizumab for Injection Revenue by Companies
3.4 Global Omalizumab for Injection Sales by Companies
3.5 Global Omalizumab for Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Omalizumab for Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Omalizumab for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Omalizumab for Injection Players in Global Market
3.8.1 List of Global Tier 1 Omalizumab for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Omalizumab for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Omalizumab for Injection Market Size Markets, 2022 & 2029
4.1.2 Subcutaneous Powder For Injection
4.1.3 Subcutaneous Solution (150 mg/mL)
4.1.4 Subcutaneous Solution(75 mg/0.5 mL)
4.2 By Type – Global Omalizumab for Injection Revenue & Forecasts
4.2.1 By Type – Global Omalizumab for Injection Revenue, 2018-2023
4.2.2 By Type – Global Omalizumab for Injection Revenue, 2024-2029
4.2.3 By Type – Global Omalizumab for Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Omalizumab for Injection Sales & Forecasts
4.3.1 By Type – Global Omalizumab for Injection Sales, 2018-2023
4.3.2 By Type – Global Omalizumab for Injection Sales, 2024-2029
4.3.3 By Type – Global Omalizumab for Injection Sales Market Share, 2018-2029
4.4 By Type – Global Omalizumab for Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Omalizumab for Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Omalizumab for Injection Revenue & Forecasts
5.2.1 By Application – Global Omalizumab for Injection Revenue, 2018-2023
5.2.2 By Application – Global Omalizumab for Injection Revenue, 2024-2029
5.2.3 By Application – Global Omalizumab for Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Omalizumab for Injection Sales & Forecasts
5.3.1 By Application – Global Omalizumab for Injection Sales, 2018-2023
5.3.2 By Application – Global Omalizumab for Injection Sales, 2024-2029
5.3.3 By Application – Global Omalizumab for Injection Sales Market Share, 2018-2029
5.4 By Application – Global Omalizumab for Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Omalizumab for Injection Market Size, 2022 & 2029
6.2 By Region – Global Omalizumab for Injection Revenue & Forecasts
6.2.1 By Region – Global Omalizumab for Injection Revenue, 2018-2023
6.2.2 By Region – Global Omalizumab for Injection Revenue, 2024-2029
6.2.3 By Region – Global Omalizumab for Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Omalizumab for Injection Sales & Forecasts
6.3.1 By Region – Global Omalizumab for Injection Sales, 2018-2023
6.3.2 By Region – Global Omalizumab for Injection Sales, 2024-2029
6.3.3 By Region – Global Omalizumab for Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Omalizumab for Injection Revenue, 2018-2029
6.4.2 By Country – North America Omalizumab for Injection Sales, 2018-2029
6.4.3 US Omalizumab for Injection Market Size, 2018-2029
6.4.4 Canada Omalizumab for Injection Market Size, 2018-2029
6.4.5 Mexico Omalizumab for Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Omalizumab for Injection Revenue, 2018-2029
6.5.2 By Country – Europe Omalizumab for Injection Sales, 2018-2029
6.5.3 Germany Omalizumab for Injection Market Size, 2018-2029
6.5.4 France Omalizumab for Injection Market Size, 2018-2029
6.5.5 U.K. Omalizumab for Injection Market Size, 2018-2029
6.5.6 Italy Omalizumab for Injection Market Size, 2018-2029
6.5.7 Russia Omalizumab for Injection Market Size, 2018-2029
6.5.8 Nordic Countries Omalizumab for Injection Market Size, 2018-2029
6.5.9 Benelux Omalizumab for Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Omalizumab for Injection Revenue, 2018-2029
6.6.2 By Region – Asia Omalizumab for Injection Sales, 2018-2029
6.6.3 China Omalizumab for Injection Market Size, 2018-2029
6.6.4 Japan Omalizumab for Injection Market Size, 2018-2029
6.6.5 South Korea Omalizumab for Injection Market Size, 2018-2029
6.6.6 Southeast Asia Omalizumab for Injection Market Size, 2018-2029
6.6.7 India Omalizumab for Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Omalizumab for Injection Revenue, 2018-2029
6.7.2 By Country – South America Omalizumab for Injection Sales, 2018-2029
6.7.3 Brazil Omalizumab for Injection Market Size, 2018-2029
6.7.4 Argentina Omalizumab for Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Omalizumab for Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Omalizumab for Injection Sales, 2018-2029
6.8.3 Turkey Omalizumab for Injection Market Size, 2018-2029
6.8.4 Israel Omalizumab for Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Omalizumab for Injection Market Size, 2018-2029
6.8.6 UAE Omalizumab for Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Omalizumab for Injection Major Product Offerings
7.1.4 Roche Omalizumab for Injection Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Omalizumab for Injection Major Product Offerings
7.2.4 Novartis Omalizumab for Injection Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
8 Global Omalizumab for Injection Production Capacity, Analysis
8.1 Global Omalizumab for Injection Production Capacity, 2018-2029
8.2 Omalizumab for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Omalizumab for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Omalizumab for Injection Supply Chain Analysis
10.1 Omalizumab for Injection Industry Value Chain
10.2 Omalizumab for Injection Upstream Market
10.3 Omalizumab for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Omalizumab for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Omalizumab for Injection in Global Market
Table 2. Top Omalizumab for Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Omalizumab for Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Omalizumab for Injection Revenue Share by Companies, 2018-2023
Table 5. Global Omalizumab for Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Omalizumab for Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Omalizumab for Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Omalizumab for Injection Product Type
Table 9. List of Global Tier 1 Omalizumab for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Omalizumab for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Omalizumab for Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Omalizumab for Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Omalizumab for Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Omalizumab for Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Omalizumab for Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Omalizumab for Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Omalizumab for Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Omalizumab for Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Omalizumab for Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Omalizumab for Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Omalizumab for Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Omalizumab for Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Omalizumab for Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Omalizumab for Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Omalizumab for Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Omalizumab for Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Omalizumab for Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Omalizumab for Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Omalizumab for Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Omalizumab for Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Omalizumab for Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Omalizumab for Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Omalizumab for Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Omalizumab for Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Omalizumab for Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Omalizumab for Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Omalizumab for Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Omalizumab for Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Omalizumab for Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Omalizumab for Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Omalizumab for Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Omalizumab for Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Omalizumab for Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Omalizumab for Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Omalizumab for Injection Sales, (K Units), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Omalizumab for Injection Product Offerings
Table 48. Roche Omalizumab for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Omalizumab for Injection Product Offerings
Table 52. Novartis Omalizumab for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Omalizumab for Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Omalizumab for Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Omalizumab for Injection Production by Region, 2018-2023 (K Units)
Table 57. Global Omalizumab for Injection Production by Region, 2024-2029 (K Units)
Table 58. Omalizumab for Injection Market Opportunities & Trends in Global Market
Table 59. Omalizumab for Injection Market Drivers in Global Market
Table 60. Omalizumab for Injection Market Restraints in Global Market
Table 61. Omalizumab for Injection Raw Materials
Table 62. Omalizumab for Injection Raw Materials Suppliers in Global Market
Table 63. Typical Omalizumab for Injection Downstream
Table 64. Omalizumab for Injection Downstream Clients in Global Market
Table 65. Omalizumab for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Omalizumab for Injection Segment by Type in 2022
Figure 2. Omalizumab for Injection Segment by Application in 2022
Figure 3. Global Omalizumab for Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Omalizumab for Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Omalizumab for Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Omalizumab for Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Omalizumab for Injection Revenue in 2022
Figure 9. By Type - Global Omalizumab for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Omalizumab for Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Omalizumab for Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Omalizumab for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Omalizumab for Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Omalizumab for Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Omalizumab for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Omalizumab for Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Omalizumab for Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Omalizumab for Injection Sales Market Share, 2018-2029
Figure 23. US Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Omalizumab for Injection Sales Market Share, 2018-2029
Figure 28. Germany Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Omalizumab for Injection Sales Market Share, 2018-2029
Figure 37. China Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Omalizumab for Injection Sales Market Share, 2018-2029
Figure 44. Brazil Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Omalizumab for Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Omalizumab for Injection Sales Market Share, 2018-2029
Figure 48. Turkey Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Omalizumab for Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Omalizumab for Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Omalizumab for Injection by Region, 2022 VS 2029
Figure 54. Omalizumab for Injection Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 注射用オマリズマブの世界市場見通し2023年-2029年(Omalizumab for Injection Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 組換えリツキシマブ注射剤のグローバル市場展望 2023年-2029年：100mg、500mg
  • グセルクマブ注射の世界市場見通し2023年-2029年
  • 硫酸ビンクリスチンリポソーム注射剤の世界市場見通し2023年-2029年
  • 緩衝髄腔内電解質&ブドウ糖注射の世界市場見通し2023年-2029年
  • 注射用カスポファンギン酢酸塩の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆